Product Code: TMRGL3694
The report provides revenue of the global pneumatic nebulizers market for the period 2017-2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global pneumatic nebulizers market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the pneumatic nebulizers market.
The report delves into the competitive landscape of the global pneumatic nebulizers market. Key players operating in the global pneumatic nebulizers market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global pneumatic nebulizers market profiled in this report.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Pneumatic Nebulizers Market
4. Market Overview
- 4.1. Introduction
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Pneumatic Nebulizers Market Analysis and Forecast, 2017-2031
- 4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
- 5.1. Technological Advancements
- 5.2. Key Industry Events
- 5.3. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Pneumatic Nebulizers Market Analysis and Forecast, by Product Type
- 6.1. Introduction & Definition
- 6.2. Key Findings/Developments
- 6.3. Market Value Forecast, by Product Type, 2017-2031
- 6.3.1. Breath-actuated Nebulizer
- 6.3.2. Vented Nebulizer
- 6.4. Market Attractiveness Analysis, by Product Type
7. Global Pneumatic Nebulizers Market Analysis and Forecast, by Application
- 7.1. Introduction & Definition
- 7.2. Key Findings/Developments
- 7.3. Market Value Forecast, by Application, 2017-2031
- 7.3.1. Chronic Obstructive Pulmonary Disease (COPD)
- 7.3.2. Asthma
- 7.3.3. Cystic Fibrosis
- 7.3.4. Others
- 7.4. Market Attractiveness Analysis, by Application
8. Global Pneumatic Nebulizers Market Analysis and Forecast, by End-user
- 8.1. Introduction & Definition
- 8.2. Key Findings/Developments
- 8.3. Market Value Forecast, by End-user, 2017-2031
- 8.3.1. Hospitals & Clinics
- 8.3.2. Home Healthcare
- 8.3.3. Others
- 8.4. Market Attractiveness Analysis, by End-user
9. Global Pneumatic Nebulizers Market Analysis and Forecast, by Region
- 9.1. Key Findings
- 9.2. Market Value Forecast, by Region, 2017-2031
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
- 9.3. Market Attractiveness Analysis, by Region
10. North America Pneumatic Nebulizers Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Market Value Forecast, by Product Type, 2017-2031
- 10.2.1. Breath-actuated Nebulizer
- 10.2.2. Vented Nebulizer
- 10.3. Market Value Forecast, by Application, 2017-2031
- 10.3.1. Chronic Obstructive Pulmonary Disease (COPD)
- 10.3.2. Asthma
- 10.3.3. Cystic Fibrosis
- 10.3.4. Others
- 10.4. Market Value Forecast, by End-user, 2017-2031
- 10.4.1. Hospitals & Clinics
- 10.4.2. Home Healthcare
- 10.4.3. Others
- 10.5. Market Value Forecast, by Country, 2017-2031
- 10.5.1. U.S.
- 10.5.2. Canada
- 10.6. Market Attractiveness Analysis
- 10.6.1. By Product Type
- 10.6.2. By Application
- 10.6.3. By End-user
- 10.6.4. By Country
11. Europe Pneumatic Nebulizers Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast, by Product Type, 2017-2031
- 11.2.1. Breath-actuated Nebulizer
- 11.2.2. Vented Nebulizer
- 11.3. Market Value Forecast, by Application, 2017-2031
- 11.3.1. Chronic Obstructive Pulmonary Disease (COPD)
- 11.3.2. Asthma
- 11.3.3. Cystic Fibrosis
- 11.3.4. Others
- 11.4. Market Value Forecast, by End-user, 2017-2031
- 11.4.1. Hospitals & Clinics
- 11.4.2. Home Healthcare
- 11.4.3. Others
- 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Italy
- 11.5.5. Spain
- 11.5.6. Rest of Europe
- 11.6. Market Attractiveness Analysis
- 11.6.1. By Product Type
- 11.6.2. By Application
- 11.6.3. By End-user
- 11.6.4. By Country/Sub-region
12. Asia Pacific Pneumatic Nebulizers Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast, by Product Type, 2017-2031
- 12.2.1. Breath-actuated Nebulizer
- 12.2.2. Vented Nebulizer
- 12.3. Market Value Forecast, by Application, 2017-2031
- 12.3.1. Chronic Obstructive Pulmonary Disease (COPD)
- 12.3.2. Asthma
- 12.3.3. Cystic Fibrosis
- 12.3.4. Others
- 12.4. Market Value Forecast, by End-user, 2017-2031
- 12.4.1. Hospitals & Clinics
- 12.4.2. Home Healthcare
- 12.4.3. Others
- 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
- 12.6. Market Attractiveness Analysis
- 12.6.1. By Product Type
- 12.6.2. By Application
- 12.6.3. By End-user
- 12.6.4. By Country/Sub-region
13. Latin America Pneumatic Nebulizers Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Product Type, 2017-2031
- 13.2.1. Breath-actuated Nebulizer
- 13.2.2. Vented Nebulizer
- 13.3. Market Value Forecast, by Application, 2017-2031
- 13.3.1. Chronic Obstructive Pulmonary Disease (COPD)
- 13.3.2. Asthma
- 13.3.3. Cystic Fibrosis
- 13.3.4. Others
- 13.4. Market Value Forecast, by End-user, 2017-2031
- 13.4.1. Hospitals & Clinics
- 13.4.2. Home Healthcare
- 13.4.3. Others
- 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
- 13.6. Market Attractiveness Analysis
- 13.6.1. By Product Type
- 13.6.2. By Application
- 13.6.3. By End-user
- 13.6.4. By Country/Sub-region
14. Middle East & Africa Pneumatic Nebulizers Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Market Value Forecast, by Product Type, 2017-2031
- 14.2.1. Breath-actuated Nebulizer
- 14.2.2. Vented Nebulizer
- 14.3. Market Value Forecast, by Application, 2017-2031
- 14.3.1. Chronic Obstructive Pulmonary Disease (COPD)
- 14.3.2. Asthma
- 14.3.3. Cystic Fibrosis
- 14.3.4. Others
- 14.4. Market Value Forecast, by End-user, 2017-2031
- 14.4.1. Hospitals & Clinics
- 14.4.2. Home Healthcare
- 14.4.3. Others
- 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
- 14.6. Market Attractiveness Analysis
- 14.6.1. By Product Type
- 14.6.2. By Application
- 14.6.3. By End-user
- 14.6.4. By Country/Sub-region
15. Competition Landscape
- 15.1. Market Player - Competition Matrix (by tier and size of companies)
- 15.2. Market Share Analysis, by Company, 2021
- 15.3. Company Profiles
- 15.3.1. Beurer GmbH
- 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.1.2. Product Portfolio
- 15.3.1.3. SWOT Analysis
- 15.3.1.4. Strategic Overview
- 15.3.2. Besco Medical Co., Ltd.
- 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.2.2. Product Portfolio
- 15.3.2.3. SWOT Analysis
- 15.3.2.4. Strategic Overview
- 15.3.3. Bremed Ltd.
- 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.3.2. Product Portfolio
- 15.3.3.3. SWOT Analysis
- 15.3.3.4. Strategic Overview
- 15.3.4. Drive DeVilbiss Healthcare
- 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.4.2. Product Portfolio
- 15.3.4.3. SWOT Analysis
- 15.3.4.4. Strategic Overview
- 15.3.5. GE HealthCare
- 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.5.2. Product Portfolio
- 15.3.5.3. SWOT Analysis
- 15.3.5.4. Strategic Overview
- 15.3.6. Koninklijke Philips N.V.
- 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.6.2. Product Portfolio
- 15.3.6.3. SWOT Analysis
- 15.3.6.4. Strategic Overview
- 15.3.7. Morepen Laboratories Ltd.
- 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.7.2. Product Portfolio
- 15.3.7.3. SWOT Analysis
- 15.3.7.4. Strategic Overview
- 15.3.8. Nidek Medical Products, Inc.
- 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.8.2. Product Portfolio
- 15.3.8.3. SWOT Analysis
- 15.3.8.4. Strategic Overview
- 15.3.9. OMRON Healthcare, Inc.
- 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.9.2. Product Portfolio
- 15.3.9.3. SWOT Analysis
- 15.3.9.4. Strategic Overview
- 15.3.10. PARI Pharma GmbH
- 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.10.2. Product Portfolio
- 15.3.10.3. SWOT Analysis
- 15.3.10.4. Strategic Overview
- 15.3.11. Rossmax International Ltd.
- 15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.11.2. Product Portfolio
- 15.3.11.3. SWOT Analysis
- 15.3.11.4. Strategic Overview
- 15.3.12. SunMed
- 15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.12.2. Product Portfolio
- 15.3.12.3. SWOT Analysis
- 15.3.12.4. Strategic Overview
- 15.3.13. Vectura Group plc
- 15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.13.2. Product Portfolio
- 15.3.13.3. SWOT Analysis
- 15.3.13.4. Strategic Overview